124
Participants
Start Date
August 13, 2021
Primary Completion Date
December 31, 2032
Study Completion Date
December 31, 2032
25mg Eluxadoline
Oral Tablets
100mg Eluxadoline
Oral Tablets
Preferred Primary Care Physicians, Inc. /ID# 227596, Pittsburgh
Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 227600, Stockbridge
Valencia Medical & Research Center /ID# 246221, Miami
Florida Research Center, Inc. /ID# 227597, Miami
IPS Research Company /ID# 227594, Oklahoma City
Kindred Medical Institute, LLC /ID# 227595, Corona
Lead Sponsor
AbbVie
INDUSTRY